Answers are grounded in this paper and cite their sources.
Background Sepsis-associated encephalopathy (SAE) affects 8–70% of critically ill sepsis patients and is associated with higher mortality, prolonged ICU stay and long-term cognitive decline. Its early diagnosis is difficult because no specific biomarker is available and bedside assessment is often confounded by sedation. Guanylate-binding protein 5 (GBP5) is an interferon- γ –inducible GTPase that promotes NLRP3 inflammasome assembly and has been implicated in sepsis-associated organ injury, but its clinical value in SAE is unknown. Methods In this multicenter, retrospective case-control study, adults (18–80 years) meeting Sepsis-3.0 criteria were enrolled at three tertiary hospitals between October 2024 and October 2025 and classified as SAE ( n = 145; GCS <15 not attributable to other causes) or non-SAE ( n = 186; GCS=15). Admission serum GBP5 and other laboratory biomarkers, including NSE, S100 β , IL-6, TNF-α, IL-10, CRP, and PCT, were measured. The cohort was randomly split into a training dataset ( n = 232) and internal validation dataset ( n = 99). Univariate comparison, multivariable logistic regression, ROC analysis and a nomogram were performed; performance was assessed by C-index, bootstrap-calibrated curves (1000 iterations) and decision curve analysis (DCA). Results Serum GBP5 was higher in SAE than in non-SAE patients (median 0.63 vs. 0.58 ng/mL, P < 0.001). Five variables were independently associated with SAE: GBP5 (OR 7.445, 95% CI 3.651–15.183), IL-6 (OR 4.472, 95% CI 2.192–9.121), APACHE II (OR 4.032, 95% CI 1.977–8.223), diabetes mellitus (OR 3.480, 95% CI 1.615–7.497) and SOFA (OR 2.364, 95% CI 1.134–4.927). GBP5 showed the highest single-marker AUC (0.813, 95% CI 0.757–0.861; cut-off >0.585 ng/mL, sensitivity 75.70%, specificity 86.40%), whereas NSE and S100 β were not retained as independent predictors. The nomogram achieved an AUC of 0.872 (95% CI 0.825–0.918) in the training and 0.864 (95% CI 0.791–0.937) in the internal validation dataset, with adequate calibration and net clinical benefit on DCA. Conclusion Admission serum GBP5 was independently associated with SAE and showed the best single-marker discrimination. A nomogram incorporating GBP5, IL-6, SOFA, APACHE II and diabetes mellitus performed well in both datasets. GBP5 may aid SAE risk stratification pending external validation.
No takes yet. Share an insight, caveat, or question.
Yang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: